Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts
Related Experiment Video
Updated: Oct 3, 2026
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
1Division of Experimental Therapeutics, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, ON M5G 2M9, Canada.
Background:
One major challenge to human cancer gene therapy, is efficient delivery of the gene-vector complex.
Methods And Results:
Using two distinct human nasopharyngeal carcinoma (NPC) models, we demonstrate that intra-tumoural (IT) administration of adenoviral-mediated wild-type p53 gene therapy (Ad-p53) caused no greater inhibition of tumour growth as compared to ionizing radiation (XRT) alone. Detailed histologic examination of tumour sections demonstrated that <15% of tumour cells were transduced by IT adv-beta-gal.
Conclusions:
This report underscores the importance of developing gene transfer vectors, which can provide therapeutic levels of transgene expression efficiently in solid tumours.
Insights
Efficient gene delivery remains a challenge for cancer gene therapy. Adenoviral-mediated wild-type p53 gene therapy showed limited tumor inhibition and transduction in nasopharyngeal carcinoma models.
Area of Science:
- Oncology
- Gene Therapy
- Cancer Research
Background:
- Efficient delivery of gene-vector complexes is a significant hurdle in human cancer gene therapy.
- Developing effective gene transfer vectors for solid tumors is crucial.
Purpose of the Study:
- To evaluate the efficacy of adenoviral-mediated wild-type p53 gene therapy (Ad-p53) in human nasopharyngeal carcinoma (NPC) models.
- To compare Ad-p53 therapy with ionizing radiation (XRT) in inhibiting tumor growth.
Main Methods:
- Utilized two distinct human nasopharyngeal carcinoma (NPC) models.
- Administered Ad-p53 intra-tumorally (IT).
- Assessed tumor growth inhibition and performed histologic examination of tumor sections to determine transduction efficiency.
Main Results:
- Intra-tumoural Ad-p53 therapy did not provide greater tumor growth inhibition compared to XRT alone.
- Histologic examination revealed that less than 15% of tumor cells were transduced by IT adv-beta-gal.
Conclusions:
- The study highlights the critical need for improved gene transfer vectors.
- Efficiently achieving therapeutic levels of transgene expression in solid tumors remains a key challenge for gene therapy.
More Related Videos
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
19:02High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
